Zosano Pharma Corporation (ZSAN): Price and Financial Metrics


Zosano Pharma Corporation (ZSAN): $0.56

0.04 (+7.23%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ZSAN to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

ZSAN Stock Price Chart Interactive Chart >

Price chart for ZSAN

ZSAN Price/Volume Stats

Current price $0.56 52-week high $37.45
Prev. close $0.52 52-week low $0.46
Day low $0.46 Volume 1,155,000
Day high $0.64 Avg. volume 425,375
50-day MA $2.52 Dividend yield N/A
200-day MA $13.86 Market Cap 2.73M

Zosano Pharma Corporation (ZSAN) Company Bio


Zosano Pharma Corporation provides biopharmaceutical products and services. The Company specializes in biopharmaceuticals, peptides, small water soluble molecules, monoclonal antibodies, and vaccines for the treatment of severe osteoporosis.


ZSAN Latest News Stream


Event/Time News Detail
Loading, please wait...

ZSAN Latest Social Stream


Loading social stream, please wait...

View Full ZSAN Social Stream

Latest ZSAN News From Around the Web

Below are the latest news stories about Zosano Pharma Corp that investors may wish to consider to help them evaluate ZSAN as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

With the long weekend over it's time to start another week of trading with the biggest pre-market stock movers for Tuesday!

William White on InvestorPlace | February 22, 2022

FDA Rejects Zosano Pharma's Application For Zolmitriptan Microneedle System Again, Shares Plunge

The FDA has issued a response letter to Zosano Pharma Corp (NASDAQ: ZSAN) regarding its resubmission of the 505(b)(2) New Drug Application for M207 (zolmitriptan microneedle system). The response letter stated that the FDA did not consider the resubmitted M207 application a complete response to the deficiencies identified in the FDA’s October 2020 Complete Response Letter. The FDA will not begin a substantive review of the application until a complete response is received. The FDA’s response let

Yahoo | February 22, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Good morning, investor!

William White on InvestorPlace | February 9, 2022

Zosano Pharma Announces Pricing of $15.4 Million Public Offering of Common Stock and Warrants

FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced the pricing of its previously announced underwritten public offering of 51,250,000 units, each consisting of one share of common stock and one warrant to purchase one share of common stock, at a public offering price of $0.30 per unit. The warrants have an exercise price of $0.30 per share, are immediately exercisable and will expire five years f

Yahoo | February 9, 2022

Zosano Pharma Announces Proposed Public Offering of Common Stock and Warrants

FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it is commencing an underwritten public offering of units consisting of shares of common stock and warrants to purchase common stock. All of the units in the offering are to be sold by Zosano. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actu

Yahoo | February 8, 2022

Read More 'ZSAN' Stories Here

ZSAN Price Returns

1-mo N/A
3-mo N/A
6-mo -92.30%
1-year -97.75%
3-year -99.06%
5-year -99.90%
YTD -96.60%
2021 -10.83%
2020 -65.32%
2019 -28.30%
2018 -79.62%
2017 -33.33%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5407 seconds.